Search results
Jump to navigation
Jump to search
Page title matches
- #REDIRECT [[Drug design#Rational drug discovery]] ...49 bytes (6 words) - 12:41, 28 March 2024
- #REDIRECT [[Drug design/ja#Rational drug discovery]] ...52 bytes (7 words) - 12:42, 28 March 2024
Page text matches
- #REDIRECT [[Drug design/ja#Rational drug discovery]] ...52 bytes (7 words) - 12:42, 28 March 2024
- #REDIRECT [[Drug design#Rational drug discovery]] ...49 bytes (6 words) - 12:41, 28 March 2024
- ...のバイオ医薬品企業である。[[:en:combinatorial chemistry|コンビナトリアルケミストリー]]ではなく、[[:en:Drug design|合理的な薬剤設計]]という明確な戦略を採用した最初のバイオテック企業の一つである。マサチューセッツ州サウスボストンに本社を置き、[[:en:San D ...ivacaftor]]は、米国における嚢胞性線維症の患者数が20万人未満であることを示す[[Wikipedia:orphan drug|orphan drug]]に指定された。2012年1月31日、Vertexは、G551D遺伝子[[:en:mutation|変異]]を有する6歳以上の患者を対象に、[[:en ...16 KB (582 words) - 19:51, 16 January 2024
- ...anagliflozin/ja|カナグリフロジン]]、[[empagliflozin/ja|エンパグリフロジン]]の3つの薬物が[[Food and Drug Administration/ja|食品医薬品局]]（FDA）に受け入れられている。カナグリフロジンは2013年3月にFDAに承認された最初のSGLT {{Anchor|Drug development}} ...21 KB (632 words) - 15:58, 14 February 2024
- ...rry|url=https://books.google.com/books?id=y8HBDAAAQBAJ&pg=PA270|title=Good Design Practices for GMP Pharmaceutical Facilities|last2=Signore|first2=Andrew A.| ...tps://books.google.com/books?id=1UH76Uw1RHcC&pg=PA6|title=Handbook of Food-Drug Interactions|last2=Frankel|first2=Eric H.|last3=Wolfe|first3=Jonathan J.|da ...5 KB (672 words) - 21:02, 15 November 2023
- ARBの発見と開発は、現代の[[rational drug design/ja|合理的薬物設計]]の好例であり、[[physiological/ja|生理学的]]システムの知識を深めるために設計をどのように利用できるかを示す {{Anchor|Drug discovery and development}} ...27 KB (998 words) - 12:39, 28 March 2024
- ...[[androstenedione]] and [[androstenediol]], both of which are currently [[Drug Enforcement Administration|banned substances]] in the United States. Howeve Prohormones vary considerably in length and design, as do peptide hormones, but their base structure is the same. They consist ...7 KB (1,035 words) - 20:02, 23 April 2024
- {{Short description|Process of bringing a new pharmaceutical drug to the market}} {{redirect|Drug research|the journal|Arzneimittelforschung{{!}}Drug Research (journal)}} ...26 KB (3,425 words) - 08:08, 4 January 2023
- ...[[androstenedione]] and [[androstenediol]], both of which are currently [[Drug Enforcement Administration|banned substances]] in the United States. Howeve Prohormones vary considerably in length and design, as do peptide hormones, but their base structure is the same. They consist ...7 KB (1,069 words) - 20:02, 23 April 2024
- ...substances have medicinal properties, they are considered [[Pharmaceutical drug|pharmaceuticals]]. ...stems, and pharmacokinetics studies the effects of biological systems on a drug. In broad terms, pharmacodynamics discusses the chemicals with biological [ ...30 KB (3,998 words) - 20:36, 8 January 2023
- ...年3月、米小売業の[[Kroger]]は、カードの高額な「スワイプ」手数料を理由に、250店舗を展開する[[:en:Smith's Food and Drug|Smith]]'sチェーンのVisaクレジットカードの利用を2019年4月3日をもって停止すると発表した。Krogerのカリフォルニア州にある[[:e ==Trademark and design== ...53 KB (1,708 words) - 14:09, 17 January 2024
- ...ARBs is a demonstrative example of modern [[rational drug design]] and how design can be used to gain further knowledge of [[physiological]] systems, in this ==Drug discovery and development== ...22 KB (3,221 words) - 10:25, 28 March 2024
- ...ARBs is a demonstrative example of modern [[rational drug design]] and how design can be used to gain further knowledge of [[physiological]] systems, in this ==Drug discovery and development== <!--T:17--> ...22 KB (3,315 words) - 10:25, 28 March 2024
- {{Drug List/ja}} | name = Pharmaceutical drug ...58 KB (1,845 words) - 17:09, 5 November 2023
- ...substances have medicinal properties, they are considered [[Pharmaceutical drug|pharmaceuticals]]. ...stems, and pharmacokinetics studies the effects of biological systems on a drug. In broad terms, pharmacodynamics discusses the chemicals with biological [ ...46 KB (5,967 words) - 12:23, 15 November 2023
- ...T-2), and are therefore also called SGLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents [[glucose]] from going into bl Three drugs have been accepted by the [[Food and Drug Administration]] (FDA) in the [[United States]]; [[dapagliflozin]], [[canag ...17 KB (2,477 words) - 09:56, 14 February 2024
- {{Short description|Pharmacological drug nomenclature}} ...Medical Association]] | access-date = 22 January 2021 }}</ref> A marketed drug might also have a company code or [[list of pharmaceutical compound number ...25 KB (3,297 words) - 17:05, 3 January 2023
- MedlinePlus provides encyclopedic information on health and drug issues, and provides a directory of medical services. MedlinePlus Connect l ...N, Kitendaugh P | title=The MedlinePlus public user interface: studies of design challenges and opportunities | journal=Journal of the Medical Library Assoc ...7 KB (955 words) - 12:10, 15 November 2023
- ...T-2), and are therefore also called SGLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents [[glucose]] from going into bl Three drugs have been accepted by the [[Food and Drug Administration]] (FDA) in the [[United States]]; [[dapagliflozin]], [[canag ...17 KB (2,553 words) - 09:56, 14 February 2024
- ...logy)|absorption]] and is the fraction (%) of an administered [[medication|drug]] that reaches the [[systemic circulation]].<ref name="Hebert 2013 pp. 17–3 ...comparing the [[Area-under-curve (pharmacokinetics)|area under the plasma drug concentration curve versus time]] (AUC) for the extravascular formulation t ...25 KB (3,394 words) - 17:46, 3 January 2023